Header cover image
  • Investing Ideas
  • Danish Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Danish Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

ALK-Abelló

Market Cap: DKK 53.9b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

ALK B

DKK 243.20

7D

-0.8%

1Y

24.5%